Media content pertaining to the business and technologies of Deep Genomics

Medicine by machine: Is A.I. the cure for the world’s ailing drug industry?

January 20, 2020

Jennifer Alsever, Fortune

Computers are sifting through an endless archive of biological data and quickly finding patterns that it would take a human a lifetime to discover.

SpaceX investor backs Toronto AI upstart's journey into the 'dark region' of genetic diseases

January 7, 2020

Amber Tong, Endpoint News

Brendan Frey set out, when he began the project to pick out a lead program for Deep Genomics, to prove that the artificial intelligence systems his lab has designed can identify new drug targets and find a winning candidate much faster than traditional methods. 

Deep Genomics nabs $40M round, doubles down on AI and Wilson disease work

January 7, 2020

Ben Adams, FierceBiotech

Canadian drug development company Deep Genomics has got off a $40 million series B round as it looks to double down on its rare genetic disease and artificial intelligence work

Deep Genomics Gathers $40 Million for AI-Based Drug Discovery

January 7, 2020

Brian Gormley,

Deep Genomics Inc. has raised $40 million in venture capital to put treatments discovered through its artificial intelligence-based drug-discovery platform to the test in human studies.

Filling in the missing pieces’: How AI is transforming drug discovery, development and innovation

April 1, 2019

Sydney Loney, National Post

'For the first time in human history, our ability to collect data on our biology has outpaced our ability to interpret and act on it'